Evidence map›Paper›PMID 40286007›Full record

ArticleMolecules (Basel, Switzerland)2025

Phenolics as Active Ingredients in Skincare Products: A Myth or Reality?

Ana Jesus, Smeera Ratanji, Honorina Cidade, Emília Sousa, Maria T Cruz, Rita Oliveira, Isabel F Almeida

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Unlocking the Potential ofFoods (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Valorization ofPlants (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana JesusAssociate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0001-7425-9750
Smeera RatanjiAssociate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0009-0006-0128-6532
Honorina CidadeLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-0715-1779
Emília SousaLaboratory of Organic and Pharmaceutical Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-5397-4672
Maria T CruzFaculty of Pharmacy, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0001-9846-6754
Rita OliveiraAssociate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Isabel F AlmeidaAssociate Laboratory i4HB-Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-1498-048X

Funding

Fundação para a Ciência e Tecnologia Ana Jesus acknowledges her Ph.D. grant with reference UI/BD/151319/2021 (https://doi.org/10.54499/UIDP/04378/2020), totally financed by FCT.Fundação para a Ciência e Tecnologia financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000012 (HealthyAging2020)Fundação para a Ciência e Tecnologia projects UIDP/04378/2020 (https://doi.org/10.54499/UIDP/04378/2020) and UIDB/04378/2020 (https://doi.org/10.54499/UIDP/04378/2020) of the Research Unit on Applied Molecular Biosciences - UCIBIOFundação para a Ciência e Tecnologia the project LA/P/0140/2020 (https://doi.org/10.54499/UIDP/04378/2020) of the Associate Labora-tory Institute for Health and Bioeconomy - i4HB the projects UIDP/04539/2020Fundação para a Ciência e Tecnologia the projects UIDP/04539/2020 and LA/P/0058/2020 from CIBBFundação para a Ciência e Tecnologia the project UIDP/04423/2020 (Group of Marine Natural Products and Medicinal Chemistry - CIIMAR)
6 · The paper itself

Abstract

Phenolic compounds, with their diverse biological activities, are widely explored as cosmetic ingredients with photoprotective, antioxidant, anti-inflammatory, and anti-hyperpigmentation properties, offering a multitargeted approach to combat photo-induced skin aging. The study analyzed 1299 cosmetic products from 2021 to 2024 to understand the market impact of phenolic compounds and their mechanism of action against photo-induced skin damage. A total of 28 active phenolic compounds were identified and the prevalence of phenolics was 13.2% in anti-aging products, 5.2% in sunscreens and 4.8% in aftersun products. Bakuchiol and polyphenols, such as resveratrol, chrysin, and hesperidin methyl chalcone, were found in anti-aging products. Sunscreens and aftersun products were counted with ferulic and caffeic acids, and salicylic acid, respectively. Antioxidant activity was found to be the primary mechanism of action of phenolic compounds by scavenging reactive species, thus mitigating oxidative stress. Ferulic and caffeic acids, chrysin, and glucosylrutin can also absorb UV radiation, acting preventively against solar-induced skin damage. This study provides insights into the limited use of phenolic compounds in commercial cosmetics, despite their diverse biological activities, and suggests potential barriers to wider use in skin and sun care products.

Indexed as

CosmeticsPhenolsSkin AgingAntioxidantsCaffeic AcidsFlavonoidsHumansPolyphenolsSunscreening AgentsUltraviolet RaysAntioxidantscaffeic acidCaffeic AcidsCosmeticsFlavonoidsPhenolsPolyphenolsSunscreening Agentsanti-aging cosmetic productsmechanism of actionphenolic compoundsskin agingsuncare cosmetic products

Identifiers

PMID40286007
PMCPMC11990743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.